BVS - Bioventus - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

BVS is currently covered by 3 analysts with an average potential upside of $7.19 (62.03%) backed by displayed 5 price targets and 15 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.67% with an average time for these price targets to be met of 1.6 days.

Highest price target for BVS is 14, Lowest price target is 2, average price target is 8.

Most recent stock forecast was given by ALEXANDER NOWAK from CRAIG HALLUM on 09-Aug-2023. First documented stock forecast 08-Mar-2021.

Best performing analysts who are covering BVS - Bioventus:

Amit Hazan Andrew Ranieri Robbie Marcus Kyle Rose Alexander Nowak

Currently, out of the existing stock ratings of BVS - 8 which are a Hold (72.73%), 3 which are a Buy (27.27%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

6

$2.7 (81.82%)

3 months 22 days ago

0/2 (0%)

$9.08 (82.36%)

Hold

2.5

$-1.5 (-37.50%)

13

1 years 1 days ago

1/3 (33.33%)

$2.62 (37.55%)

8

Buy

25

1 years 22 days ago

0/1 (0%)

$8.71 (53.47%)

Buy

11

$8.81 (402.28%)

12

1 years 1 months 20 days ago

0/5 (0%)

$4.05 (36.96%)

Buy

23

$22.02 (2246.94%)

2 years 8 months 23 days ago

0/1 (0%)

$11.49 (99.83%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BVS (Bioventus) average time for price targets to be met?

On average it took 1.6 days on average for the stock forecasts to be realized with a an average price target met ratio 6.67

Which analyst has the current highest performing score on BVS (Bioventus) with a proven track record?

AMIT HAZAN

Which analyst has the current lower performing score on BVS (Bioventus) with a proven track record?

ALEXANDER NOWAK

Which analyst has the most public recommendations on BVS (Bioventus)?

Amit Hazan works at GOLDMAN SACHS and has 8 price targets and 6 ratings on BVS

Which analyst is the currently most bullish on BVS (Bioventus)?

Kyle Rose with highest potential upside - $22.02

Which analyst is the currently most reserved on BVS (Bioventus)?

Amit Hazan with lowest potential downside - -$1.5

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart